While many of the principles reflect existing expectations around safe practice, the new Regulation provides much greater detail on how clinical governance should be demonstrated and documented.
The NSW Government has released the Medicines, Poisons and Therapeutic Goods Regulation 2026, introducing a new regulatory framework for the prescribing, supply, storage and administration of medicines across New South Wales. Here's what it means for your cosmetic nurses and aesthetic clinics, and how Juv'ae360 already helps.
The Regulation comes into effect on 5 November 2026 and includes important changes for cosmetic nurses and clinic owners. While many of the principles reflect existing expectations around safe practice, the new Regulation provides much greater detail on how clinical governance should be demonstrated and documented.
One of the most significant developments is that, for the first time, cosmetic medicine has its own dedicated section within NSW legislation.
Part 9 of the Regulation spans four pages and focuses specifically on cosmetic use substances. It introduces requirements relating to:
Administration of cosmetic use substances
Administration by nurses under the direction of medical practitioners and nurse practitioners
Prescribing directions
Record keeping
Storage
Duties of responsible providers and staff
Category 1 and Category 2 governance requirements
This reflects the continued evolution of cosmetic medicine as a highly regulated area of healthcare, with greater emphasis on governance, accountability and patient safety.
The Regulation places increased emphasis on:
Clinical governance
Prescriber oversight
Accurate patient records
Medicine traceability
Documentation standards
Audit readiness
For cosmetic practitioners, compliance extends beyond administering medicines safely. There is now a stronger expectation that every stage of the patient's clinical journey can be clearly demonstrated through accurate documentation, appropriate prescribing, and effective clinical oversight.
One of the strongest themes throughout the new Regulation is the importance of maintaining complete and accessible clinical records. This includes:
Current prescribing directions
Comprehensive treatment records
Batch number documentation
Complete clinical notes
Clear evidence of prescriber oversight
The Regulation also reinforces the importance of prescribing practitioners having visibility of the patient's clinical record, to support informed clinical decision-making and ongoing patient care.
For many aesthetic clinics , this highlights the importance of working within a single clinical system, rather than relying on multiple disconnected platforms or paper records.
A notable change within the Regulation is the introduction of Category 1 and Category 2 requirements for cosmetic medicine.
These are not simply recommendations or best practice guidelines. Failure to comply with certain provisions may constitute an offence under the Medicines, Poisons and Therapeutic Goods Act 2022 and may attract significant penalties.
The obligations extend beyond the treating nurse and also apply to prescribing practitioners and responsible providers, reinforcing the importance of strong governance, accurate documentation and appropriate clinical oversight.
As regulatory expectations continue to evolve, technology plays an increasingly important role in supporting compliant clinical practice.
Many of the governance principles outlined in the new Regulation have already been incorporated into Juv'ae360, Juv'ae's proprietary software platform designed specifically for cosmetic medicine.
Juv'ae360 helps cosmetic nurse practitioners:
Support compliant prescribing workflows
Maintain a complete digital clinical record
Record medicine batch numbers and treatment details
Give prescribing practitioners visibility of patient records
Maintain records that are secure and audit-ready
Rather than adding administrative burden, the platform has been designed to embed compliance into everyday clinical practice while supporting safe, high-quality patient care.
If you're using Juv'ae360, you've got a head start on what this Regulation now expects.
The new Regulation represents an important step in strengthening clinical governance across cosmetic medicine in New South Wales.
Over the coming weeks, our Clinical Governance Committee will be releasing practical resources to help cosmetic nurses and aesthetic clinic owners understand the new requirements before they come into effect on 5 November 2026. This will include:
Plain English summaries of the Regulation
Educational webinars
Practical compliance resources
Guidance on implementing the changes in everyday clinical practice
Juv'ae360 nurses get exclusive access to these sessions as part of the platform.
As the industry continues to evolve, our goal remains the same: to support practitioners with practical education, strong clinical governance and systems that help deliver safe, compliant patient care.
In the meantime, visit the NSW Health website for updates, or Download the Medicines, Poisons and Therapeutic Goods Regulation 2026 (NSW) here (updated as of 6/7/2026).
Not a Juv'ae nurse? Join the community that supports you through regulatory change, clinical governance and everyday compliance, so you're never navigating it alone